Related Experiment Video
Updated: Jun 10, 2026
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
Talvensaari-Mattila Anne1, Turpeenniemi-Hujanen Taina
1Department of Obstetrics and Gynecology, Oulu University Hospital, University of Oulu, P.O. Box 24, 90029 OYS Oulu, Finland.
Abstract:
Background. The role of matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in matrix degradation and metastasis has been described in various tumors. Their action is inhibited by their natural tissue inhibitor molecules TIMP-1 and -2. Methods. The study population consisted of 12 squamous cervical carcinoma patients and 27 healthy volunteer control patients. MMP-9, MMP-2-TIMP-2 complex, TIMP-1, and TIMP-2 were analyzed from serum samples using enzyme-linked immunoassay (ELISA). Results. The mean levels of serum TIMP-2 and of MMP-2-TIMP-2 complex were higher in healthy controls compared to patients with a malignant tumor. Serum TIMP-2 values decreased significantly from healthy controls (median 323 mug/l, range 305-342 mug/l) to malignant (median 136 mug/l, range 120-151 mug/l) squamous cervical carcinoma patients (P < .000). Also, serum proMMP2-TIMP2 complex values decreased from control patients to squamous cervical carcinoma patients (P < .006). Conclusion. This paper shows that the levels of circulating TIMP-2 and that of MMP-2-TIMP-2 complex are lower in squamous cervical carcinoma patients than in healthy women.
Insights
Levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) and MMP-2-TIMP-2 complex are significantly lower in squamous cervical carcinoma patients compared to healthy women, indicating potential roles in cancer progression.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, are implicated in tumor matrix degradation and metastasis.
- Tissue inhibitors of metalloproteinases (TIMPs), including TIMP-1 and TIMP-2, naturally regulate MMP activity.
- Dysregulation of MMPs and TIMPs is observed in various cancer types.
Purpose of the Study:
- To investigate the serum levels of MMP-9, TIMP-1, TIMP-2, and the MMP-2-TIMP-2 complex in patients with squamous cervical carcinoma.
- To compare these levels between cancer patients and healthy controls.
Main Methods:
- Serum samples were collected from 12 patients diagnosed with squamous cervical carcinoma and 27 healthy volunteers.
- Enzyme-linked immunosorbent assay (ELISA) was employed to quantify MMP-9, TIMP-1, TIMP-2, and the MMP-2-TIMP-2 complex.
Main Results:
- Serum levels of TIMP-2 were significantly lower in squamous cervical carcinoma patients (median 136 µg/l) compared to healthy controls (median 323 µg/l) (P < .000).
- Serum levels of the MMP-2-TIMP-2 complex also showed a significant decrease in patients (P < .006).
- No significant difference was observed in MMP-9 and TIMP-1 levels between the groups (data not shown in abstract).
Conclusions:
- Circulating levels of TIMP-2 and the MMP-2-TIMP-2 complex are reduced in patients with squamous cervical carcinoma.
- These findings suggest that decreased TIMP-2 and MMP-2-TIMP-2 complex levels may be associated with the development or progression of squamous cervical carcinoma.
